New Era of Cataract Surgery Introduced at SurgiSite Boston

WALTHAM, Mass.--(BUSINESS WIRE)--Medical firsts are expected in Boston, but they are not limited to academic medical centers. Here’s the proof: SurgiSite Boston (www.surgisiteboston.com) – an eye surgery facility in Waltham MA – performed the first laser-assisted cataract surgery in Massachusetts. This unique “first” was performed by SurgiSite Medical Director Jonathan H. Talamo, MD in December 2012. Dozens more ‘bladeless cataract surgeries’ – as they have come to be known – have been performed successfully in the weeks since, and both cataract surgeons and patients have raved about the speed, safety and rapid recovery.

SurgiSite Boston, now in its seventh year, is a stunningly modern ambulatory surgery center that is used by 70 ophthalmologists from throughout the region. It was created by Andrew Gillies, MD, President of SurgiSite Boston, and Jay S. Duker, MD, Director of New England Eye Center at Tufts Medical Center. SurgiSite aims to best serve both patients and physicians by acting quickly to adopt new technologies and create a comfortable, accessible environment for treatment.

The Catalys® Precision Laser system (www.optimedica.com) “is the result of unprecedented advances in image-guided laser eye surgery. It is gentle and patient-friendly, causing little or no discomfort while performing key steps of cataract surgery with superb precision and accuracy,” according to Dr. Talamo who was pleased to be among the first in the nation – certainly the first in Boston – to use the Catalys system in the operating room.

source: Business Wire

PRN Physician Recommended Nutriceuticals and Scope Ophthalmics launch Omega Eye in the UK

PRN Physician Recommended Nutriceuticals, a premier producer of condition-specific omega-3 products and macular vitamins, and Scope Ophthalmics, a leading distributor of innovative ophthalmic products in the UK, today announced the launch of Omega Eye in the United Kingdom and Ireland. The introduction of Omega Eye to the UK market is a significant enhancement to the treatments currently available for patients suffering from dry eye symptoms. The product offers a daily dose of 2668mg of omega-3 fatty acids in the re-esterified triglyceride form, including 1680mg of EPA and 560mg of DHA, as well as 1000 IU of Vitamin D.

With the current UK dry eye market estimated at 13MM units/annum, the market is growing at 12%/year. Experts say that this market will grow substantially in the coming years due to the aging population in the UK and also the environmental changes that can lead to dry eye symptoms. At present, 10% of the UK population suffers from some form of dry eye sensation. As a result, omega-3 supplementation, already proving its value as an essential part of dry eye therapy in the United States, is quickly becoming a topic of interest among UK ophthalmologists.

source: PRN Neutriceuticals

LASIK Vision Institute Congratulates Pioneers of LASIK Surgery

The LASIK Vision Institute (LVI) extends its heartfelt congratulations to the pioneers behind LASIK surgery for being awarded the National Medal of Technology and Innovation. Inventor Gholam A. Peyman and researchers Samuel Blum, James J. Wynne and Rangaswamy Srinivasan were all honored in a White House ceremony late last week.

The Unites States’ most prestigious honor of its kind, the national award recognizes leading innovators for technological achievement. President Obama personally bestowed the medal upon Peyman, Wynne and Srinivasan. Scientist Samuel Blum passed away last month and received the award posthumously.

“Laser refractive surgical techniques… have revolutionized vision enhancement,” said President Obama in his ceremony address. “I want to congratulate these extraordinary Americans once again for all their accomplishments.”

source: PR Web